Clearance Summary
CURAD received FDA 510(k) clearance under submission number K022645, sponsored by Beiersdorf AG. The device was reviewed via the Traditional premarket notification pathway and assigned to the General Hospital review panel. The statutory decision date of record is 2002-11-05.
- Submission: K022645
- Applicant / Sponsor: Beiersdorf AG
- Clearance pathway: Traditional
- Review panel: General Hospital
- Device class: Class I
- Regulation citation: 21 CFR 880.5090
- Decision date: 2002-11-05
Classification & Regulation
This clearance is catalogued under FDA product code KMF and 21 CFR 880.5090, within the General Hospital review panel as a Class I device.